Bioresponsive nanosensors in medical imaging

Journal of the Royal Society Interface

Volumn 7, Issue SUPPL. 1, 2010, Pages

  Schellenberger, Eyk ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Apoptosis imaging; Enzyme activity; Iron oxide particles; Matrix metalloproteinase; Superparamagnetic

Indexed keywords

CELL DEATH; ENZYME ACTIVITY; ENZYMES; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; NANOMAGNETICS; NANOSENSORS; RESONANCE; SUPERPARAMAGNETISM;

ANIONIC CITRATE; APOPTOSIS IMAGING; IRON OXIDE PARTICLES; MATRIX METALLOPROTEINASES; SENSITIVE PROBE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SUPERPARAMAGNETICS;

IRON OXIDES;

GELATINASE B; IRON OXIDE; NANOPARTICLE; PROTEINASE; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; VERY SMALL IRON OXIDE PARTICLE; ANNEXIN; CITRIC ACID; DIAGNOSTIC AGENT; FERRIC ION; FERRIC OXIDE; FLUORESCENT DYE; NANOMATERIAL;

APOPTOSIS; CRYSTAL STRUCTURE; DIAGNOSTIC IMAGING; ENZYME ACTIVITY; IN VIVO STUDY; NANOSENSOR; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; CHEMICAL STRUCTURE; CHEMISTRY; INSTRUMENTATION; MAGNETISM; METHODOLOGY; PHYSIOLOGY; STATIC ELECTRICITY;

ANNEXINS; APOPTOSIS; CITRIC ACID; DIAGNOSTIC IMAGING; FERRIC COMPOUNDS; FLUORESCENT DYES; MAGNETIC RESONANCE IMAGING; MAGNETICS; MODELS, MOLECULAR; NANOSTRUCTURES; STATIC ELECTRICITY;

EID: 77951918638     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2009.0336.focus     Document Type: Review

References (41)

1. Arén, C. 1990 Heparin and protamine therapy. Semin. Thorac. Cardiovasc. Surg. 2, 364-372.
2. Bartling, B., Holtz, J. & Darmer, D. 1998 Contribution of myocyte apoptosis to myocardial infarction? Basic Res. Cardiol. 93, 71-84. (doi:10.1007/s003950050065)
3. Belhocine, T., Steinmetz, N., Hustinx, R., Bartsch, P., Jerusalem, G., Seidel, L., Rigo, P. & Green, A. 2002 Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin. Cancer Res. 8, 2766-2774.
4. Belhocine, T., Steinmetz, N., Green, A. & Rigo, P. 2003 In vivo imaging of chemotherapy-induced apoptosis in human cancers. Ann. NY Acad. Sci. 1010, 525-529. (doi:10.1196/annals.1299.097)
5. Bremer, C., Tung, C. H. & Weissleder, R. 2001 In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat. Med. 7, 743-748. (doi:10.1038/89126)
6. Corot, C., Robert, P., Idee, J. M. & Port, M. 2006 Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev. 58, 1471-1504. (doi:10.1016/j.addr.2006.09.013)
7. Dumont, E. A. et al. 2000 Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model. Circulation 102, 1564-1568.
8. Haas, R. L., de Jong, D., Valdés Olmos, R. A., Hoefnagel, C. A., van den Heuvel, I., Zerp, S. F., Bartelink, H. & Verheij, M. 2004 In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. Int. J. Radiat. Oncol. Biol. Phys. 59, 782-787. (doi:10.1016/j.ijrobp.2003.11.017)
9. Hoebers, F. J., Kartachova, M., de Bois, J., van den Brekel, M. W., van Tinteren, H., van Herk, M., Rasch, C. R., Valdés Olmos, R. A. & Verheij, M. 2008 99mTc Hynicrh-annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy. Eur. J. Nucl. Med. Mol. Imaging 35, 509-518. (doi:10.1007/s00259-007-0624-x)
10. Hofstra, L. et al. 2000 Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 356, 209-212. (doi:10.1016/S0140- 6736(00)02482-X)
11. Hu, J., Van den Steen, P. E., Sang, Q. X. & Opdenakker, G. 2007 Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat. Rev. Drug Discov. 6, 480-498. (doi:10.1038/nrd2308)
12. Jaques, L. B. 1973 Protamine-antagonist to heparin. Can. Med. Assoc. J. 108, 1291-1297.
13. Josephson, L., Perez, J. M. & Weissleder, R. 2001 Magnetic nanosensors for the detection of oligonucleotide sequences. Angew. Chem. Int. Ed. 40, 3204-3206. (doi:10.1002/1521-3773(20010903)40:17〈3204::AID- ANIE3204〉3.0.CO;2-H)
14. Kartachova, M., Haas, R. L., Olmos, R. A., Hoebers, F. J., van Zandwijk, N. & Verheij, M. 2004 In vivo imaging of apoptosis by 99mTc-annexin V scintigraphy: visual analysis in relation to treatment response. Radiother. Oncol. 72, 333-339. (doi:10.1016/j.radonc.2004.07.008)
15. Kemerink, G. J., Boersma, H. H., Thimister, P. W., Hofstra, L., Liem, I. H., Pakbiers, M. T., Janssen, D., Reutelingsperger, C. P. & Heidendal, G. A. 2001 Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans. Eur. J. Nucl. Med. 28, 1373-1378.
16. Kerr, J. F., Wyllie, A. H. & Currie, A. R. 1972 Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257.
17. Koh, I., Hong, R., Weissleder, R. & Josephson, L. 2008 Sensitive NMR sensors detect antibodies to influenza. Angew. Chem. Int. Ed. 47, 4119-4121. (doi:10.1002/anie200800069)
18. Kurihara, H., Yang, D. J., Cristofanilli, M., Erwin, W. D., Yu, D. F., Kohanim, S., Mendez, R. & Kim, E. E. 2008 Imaging and dosimetry of 99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors. Appl. Radiat. Isot. 66, 1175-1182. (doi:10.1016/j.apradiso.2008.01.012)
19. Lorberboym, M., Blankenberg, F. G., Sadeh, M. & Lampl, Y. 2006 In vivo imaging of apoptosis in patients with acute stroke: correlation with blood-brain barrier permeability. Brain Res. 1103, 13-19. (doi:10.1016/j. brainres.2006.05.073)
20. Mani, K. & Kitsis, R. N. 2003 Myocyte apoptosis: programming ventricular remodeling. J. Am. Coll. Cardiol. 41, 761-764. (doi:10.1016/S0735- 1097(02)02958-3)
21. Ntziachristos, V., Ripoll, J., Wang, L. V. & Weissleder, R. 2005 Looking and listening to light: the evolution of whole-body photonic imaging. Nat. Biotechnol. 23, 313-320. (doi:10.1038/nbt1074)
22. Patel, A. A., White, C. M. & Coleman, C. I. 2007 Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention. Conn. Med. 71, 93-95.
23. Perez, J. M., Josephson, L., O'Loughlin, T., Hogemann, D. & Weissleder, R. 2002 Magnetic relaxation switches capable of sensing molecular interactions. Nat. Biotechnol. 20, 816-820.
24. Rottey, S., Slegers, G., Van Belle, S., Goethals, I. & Van de Wiele, C. 2006 Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy. J. Nucl. Med. 47, 1813-1818.
25. Schellenberger, E. A., Bogdanov, A. J., Hogemann, D., Tait, J., Weissleder, R. & Josephson, L. 2002 Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. Mol. Imaging 1, 102-107.
26. Schellenberger, E. A., Reynolds, F., Weissleder, R. & Josephson, L. 2004a Surface-functionalized nanoparticle library yields probes for apoptotic cells. Chembiochem Eur. J. Chem. Biol. 5, 275-279. (doi:10.1002/cbic.200300713)
27. Schellenberger, E. A., Weissleder, R. & Josephson, L. 2004b Optimal modification of annexin V with fluorescent dyes. Chembiochem Eur. J. Chem. Biol. 5, 271-274. (doi:10.1002/cbic.200300741)
28. Schellenberger, E. A., Sosnovik, D., Weissleder, R. & Josephson, L. 2004c Magneto/optical annexin V, a multimodal protein. Bioconjug. Chem. 15, 1062-1067. (doi:10.1021/bc049905i)
29. Schellenberger, E., Rudloff, F., Warmuth, C., Taupitz, M., Hamm, B. & Schnorr, J. 2008 Protease-specific nanosensors for magnetic resonance imaging. Bioconjug. Chem. 19, 2440-2445. (doi:10.1021/bc800330k)
30. Shi, B., Fang, C. & Pei, Y. 2006 Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity. J. Pharm. Sci. 95, 1873-1887. (doi:10.1002/jps.20491)
31. Simberg, D. et al. 2007 Biomimetic amplification of nanoparticle homing to tumors. Proc. Natl Acad. Sci. USA 104, 932-936. (doi:10.1073/pnas.0610298104)
32. Sosnovik, D. E. et al. 2005 Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn. Reson. Med. 54, 718-724.
33. Taupitz, M., Wagner, S., Schnorr, J., Kravec, I., Pilgrimm, H., Bergmann-Fritsch, H. & Hamm, B. 2004 Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging. Invest. Radiol. 39, 394-405. (doi:10.1097/01.rli.0000129472.45832.b0)
34. Thiesen, B. & Jordan, A. 2008 Clinical applications of magnetic nanoparticles for hyperthermia. Int. J. Hyperthermia 24, 467-474. (doi:10.1080/02656730802104757)
35. VanMeter, T. E., Rooprai, H. K., Kibble, M. M., Fillmore, H. L., Broaddus, W. C. & Pilkington, G. J. 2001 The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J. Neurooncol. 53, 213-235. (doi:10.1023/A:1012280925031)
36. Wagner, S., Schnorr, J., Pilgrimm, H., Hamm, B. & Taupitz, M. 2002 Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization. Invest. Radiol. 37, 167-177. (doi:10.1097/00004424-200204000-00002)
37. Warmuth, C., Schnorr, J., Kaufels, N., Wagner, S., Pilgrimm, H., Hamm, B. & Taupitz, M. 2007 Wholeheart coronary magnetic resonance angiography: contrast-enhanced high-resolution, time-resolved 3D imaging. Invest. Radiol. 42, 550-557. (doi:10.1097/RLI.0b013e31803c4a5a)
38. Weissleder, R. 2002 Scaling down imaging: molecular mapping of cancer in mice. Nat. Rev. Cancer 2, 11-18. (doi:10.1038/nrc701)
39. Weissleder, R. & Pittet, M. J. 2008 Imaging in the era of molecular oncology. Nature 452, 580-589. (doi:10.1038/nature06917)
40. Weissleder, R., Tung, C. H., Mahmood, U. & Bogdanov, A. J. 1999 In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotechnol. 17, 375-378. (doi:10.1038/7933)
41. Yagle, K. J., Eary, J. F., Tait, J. F., Grierson, J. R., Link, J. M., Lewellen, B., Gibson, D. F. & Krohn, K. A. 2005 Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis. J. Nucl. Med. 46, 658-666.